Dolphin Medical Services Ltd.
Snapshot View

1.69 ▼0%

06 February 2023, 04:01:00 PM

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Hospital & Healthcare Services Compare with Industry peers
Website http://www.dolphinmedicalindia.com
Market Cap 2.55 Cr.
Enterprise Value(EV) 3.25 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) -0.09 Trailing Twelve Months Ending 2022-09
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2022-09
Industry PE 46.62 Trailing Twelve Months Ending 2022-09
Book Value / Share 6.80 Trailing Twelve Months Ending 2022-09
Price to Book Value 0.25 Calculated using Price: 1.69
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 1.51 Cr. 15,099,952 Shares
FaceValue 10
Company Profile
Dolphin Medical Services Ltd. is an organization promoted by the doctors of the region. The chief promoters are Dr. M S S Koteswara Rao, an eminent physician and former Minister for health in Andhra Pradesh and Dr. G V Mohan Prasad, a radiologist cum ENT specialist who is also the Managing Director of the company. Dolphin was founded with a lofty ideal of providing quality medical services to improve the quality of life of the people through better health, in the last decade of the the 20th century by renowned medical technologists.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
1 Week
+1.20%
1 Month
-7.65%
3 Month
+1.81%
6 Month
-12.44%
1 Year
-38.55%
2 Year
-7.65%
5 Year
+13.42%
10 Year
+25.19%
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) -6.26 -4.39 -0.36 -2.12 -2.41 -8.60 -3.50 -2.93 -1.80
Return on Capital Employed (%) -3.68 -2.56 -0.06 -1.43 -1.57 -5.38 -2.07 -2.01 -1.50
Return on Assets (%) -3.80 -2.62 -0.21 -1.25 -1.41 -5.15 -2.15 -2.07 -1.53

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 13 13 13 12 12 11 11 10 10 10
Non Curr. Liab. 9 9 9 9 9 7 7 1 1 1
Curr. Liab. 0 0 0 0 0 0 0 1 1 1
Minority Int.
Equity & Liab. 22 22 22 21 21 18 18 12 12 12
Non Curr. Assets 21 20 20 19 19 16 16 10 10 10
Curr. Assets 2 2 2 2 2 2 2 2 2 2
Misc. Exp. not W/O
Total Assets 22 22 22 21 21 18 18 12 12 12

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales 1 0 1 0 0 0 0 0 1 1
Other Income 0 0 0 0 0 0 6 0 0
Total Income 1 0 1 0 0 0 0 6 1 1
Total Expenditure -1 0 0 0 0 -1 -1 -6 -1 -1
PBIDT 0 0 0 0 0 -1 0 0 0 0
Interest 0 0 0 0 0 0 0 0 0 0
Depreciation -1 -1 0 0 0 0 0 0 0 0
Taxation 0 0 0 0 0 0 0 0 0
Exceptional Items
PAT -1 -1 0 0 0 -1 0 0 0 0
Adjusted EPS -1 0 0 0 0 -1 0 0 0 0

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 0 0 0 0 0 0 0 0 0
Cash Fr. Inv. 0 0 0 0 2 0
Cash Fr. Finan. 0 0 0 0 0 -2 0 0 0
Net Change 0 0 0
Cash & Cash Eqvt 0 0 0 0 0 0 0 0 0

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 26.44 26.44 26.44 26.44 26.44 26.44 26.44 26.44 26.44
Public 73.56 73.56 73.56 73.56 73.56 73.56 73.56 73.56 73.56
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Mon, 06 Feb 2023
Board Meeting Intimation for To Consider And Approve Unaudited Results For The Quater Ended 31.12.2022
DOLPHIN MEDICAL SERVICES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2023 inter alia to consider and approve unaudited results for the quater ended 31.12.2022
Tue, 03 Jan 2023
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Compliance Certificate under Reg.7(5)
Sat, 31 Dec 2022
Closure of Trading Window
Closure of Trading Window

Technical Scans View Details >>

Mon, 06 Feb 2023
Higher Delivery Quantity Higher Delivery Quantity
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity
Close Crossing Last Month Close From Below Close Crossing Last Month Close From Below
Close Within 52 Week Low Zone Close Within 52 Week Low Zone

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 241,289.12 997.90 -0.8%
Cipla Ltd. 83,244.79 1,024.50 -0.7%
Dr. Reddy's Laboratories Ltd. 73,968.14 4,447.75 +0.2%
Divi's Laboratories Ltd. 72,982.62 2,768.95 +0.7%
Apollo Hospitals Enterprise Ltd. 62,084.06 4,318.00 +0.1%
Torrent Pharmaceuticals Ltd. 51,953.07 1,533.05 -0.2%
Zydus Lifesciences Ltd. 48,525.07 476.75 -0.6%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 57.29 997.90 -0.8%
Cipla Ltd. Consolidated 2022-12 31.56 1,024.50 -0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 20.30 4,447.75 +0.2%
Divi's Laboratories Ltd. Consolidated 2022-12 30.45 2,768.95 +0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 74.00 4,318.00 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 62.45 1,533.05 -0.2%
Zydus Lifesciences Ltd. Consolidated 2022-12 23.54 476.75 -0.6%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.36 997.90 -0.8%
Cipla Ltd. Consolidated 2022-12 3.67 1,024.50 -0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.36 4,447.75 +0.2%
Divi's Laboratories Ltd. Consolidated 2022-12 5.87 2,768.95 +0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 10.38 4,318.00 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.14 1,533.05 -0.2%
Zydus Lifesciences Ltd. Consolidated 2022-12 2.81 476.75 -0.6%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 997.90 -0.8%
Cipla Ltd. Consolidated 2022-03 0.04 1,024.50 -0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,447.75 +0.2%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 2,768.95 +0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,318.00 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,533.05 -0.2%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 476.75 -0.6%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 997.90 -0.8%
Cipla Ltd. Consolidated 2022-03 13.10 1,024.50 -0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,447.75 +0.2%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,768.95 +0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,318.00 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,533.05 -0.2%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 476.75 -0.6%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 997.90 -0.8%
Cipla Ltd. Consolidated 2022-03 13.10 1,024.50 -0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,447.75 +0.2%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,768.95 +0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,318.00 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,533.05 -0.2%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 476.75 -0.6%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 997.90 -0.8%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,024.50 -0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,447.75 +0.2%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 2,768.95 +0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,318.00 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,533.05 -0.2%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 476.75 -0.6%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 997.90 -0.8%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,024.50 -0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,447.75 +0.2%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 2,768.95 +0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,318.00 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,533.05 -0.2%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 476.75 -0.6%

FAQ's On Dolphin Medical Services Ltd.

What is Dolphin Medical Serv share price?

Can I buy Dolphin Medical Serv shares now?

What is the Market Cap of Dolphin Medical Serv?

What are the key metrics to analyse Dolphin Medical Serv?

What is the 52 Week High and Low of Dolphin Medical Serv?